Olympus Corporation (OCPNF)
OTCMKTS · Delayed Price · Currency is USD
12.78
0.00 (0.00%)
At close: Dec 30, 2025
Olympus Market Cap
Olympus has a market cap or net worth of $14.71 billion as of January 7, 2026. Its market cap has decreased by -16.19% in one year.
Market Cap
14.71B
Enterprise Value
15.26B
Revenue
6.61B
Ranking
n/a
PE Ratio
22.19
Stock Price
$12.78
Market Cap Chart
Since January 16, 1992, Olympus's market cap has increased from 2.39B to 14.71B, an increase of 514.51%. That is a compound annual growth rate of 5.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 14.71B | 5.17% |
| Dec 30, 2025 | 13.98B | -17.80% |
| Dec 30, 2024 | 17.01B | -1.61% |
| Dec 29, 2023 | 17.29B | -23.63% |
| Dec 30, 2022 | 22.64B | -23.48% |
| Dec 30, 2021 | 29.58B | 5.35% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 781.81M |
| Glass House Brands | 714.29M |
| Elite Pharmaceuticals | 537.20M |
| Northwest Biotherapeutics | 499.37M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 342.98M |
| Silence Therapeutics | 280.10M |